دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes
Valeria Paradies, MD, a,b Adrian Banning, MD, PH D, c,d Davide Cao, MD, e,f Alaide Chieffo, MD, g Joost Daemen, MD, PHD, b Roberto Diletti, MD, PH D, b David Hildick-Smith, MD, P HD, h David E. Kandzari, MD,i Ajay J. Kirtane, MD, SM, j,k Roxana Mehran, MD, P HD, e Duk-Woo Park, MD, l Giuseppe Tarantini, MD, P HD, m Pieter C. Smits, MD, P HD, a Nicolas M. Van Mieghem, MD, PHD
doi : 10.1016/j.jcin.2022.12.022
Volume 16, Issue 7, 10 April 2023, Pages 743-758
A Randomized Comparison of 2 Different Drug-Coated Balloons for In-Stent Restenosis
Shengwen Liu, MD,a Yujie Zhou, MD,b Zhujun Shen, MD,c Hui Chen, MD,d Chunguang Qiu, MD,e Guosheng Fu, MD,f Hui Li, MD, g Zaixin Yu, MD,h Qiutang Zeng, MD,i Zhanquan Li, MD, j Wei Li, P HD, k Shubin Qiao, MD,a on behalf of the Dissolve ISR Investigators
doi : 10.1016/j.jcin.2022.12.018
Volume 16, Issue 7, 10 April 2023, Pages 759-767
Although use of drug-coated balloons (DCB) is a promising technique, little is known about the clinical efficacy of the Dissolve DCB in drug-eluting stent (DES) in-stent restenosis (ISR).
Coronary Drug-Coated Balloon Angioplasty: What Are the Next Steps?∗
RóisÃn Colleran, MB BC H, a,b Seán Fitzgerald, MB BCH ,a,b Robert A. Byrne, MB BC H, PH D
doi : 10.1016/j.jcin.2023.01.382
Volume 16, Issue 7, 10 April 2023, Pages 768-770
Assessment of Paclitaxel Drug-Coated Balloon Only Angioplasty in STEMI
Ioannis Merinopoulos, MD, MSC ,a,b Tharusha Gunawardena, MD, BS C ,a,b Natasha Corballis, MD, a,b U. Bhalraam, BSC , MD,a,b Johannes Reinhold, MD, PH D, a,b Upul Wickramarachchi, MD, a,b Clint Maart, MD,a Tim Gilbert, MD,a Paul Richardson, BSC ,a Sreekumar Sulfi, MD,a Toomas Sarev, MD,a Chris Sawh, MD,a Trevor Wistow, MD,a Alisdair Ryding, MD, P HD, a Mohamed O. Mohamed, MD, PH D, c,d Aris Perperoglou, P HD, e Mamas A. Mamas, MD, DPHIL ,c Vassilios S. Vassiliou, MD, P HD, a,b ,* Simon C. Eccleshall, MD a
doi : 10.1016/j.jcin.2023.01.380
Volume 16, Issue 7, 10 April 2023, Pages 771-779
Primary percutaneous coronary intervention (pPCI) with drug-eluting stents (DES) has emerged as the standard of care, but stent-related events have persisted. Drug-coated balloon (DCB)–only angioplasty is an emerging technology, although it is not fully evaluated compared with DES in the context of pPCI.
Drug-Coated Balloon Angioplasty in Acute Myocardial Infarction: Tailored Therapy Beyond the Lifelong Implant?∗
Nicola Vos, MD, PH D, Maarten Vink, MD, PHD
doi : 10.1016/j.jcin.2023.02.026
Volume 16, Issue 7, 10 April 2023, Pages 780-782
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial
Simone Biscaglia, MD,a Filippo Maria Verardi, MD,a Matteo Tebaldi, MD, a Vincenzo Guiducci, MD,b Serena Caglioni, MD,a Roberta Campana, MD,a Antonella Scala, MD,a Andrea Marrone, MD,a Graziella Pompei, MD,a Federico Marchini, MD, a Davide Scancarello, MD,a Gianluca Pignatelli, MD, b Sergio Musto D’Amore, MD, b Iginio Colaiori, MD, b Pierluigi Demola, MD, b Luigi Di Serafino, MD, c Carlo Tumscitz, MD,a Carlo Penzo, MD,a Andrea Erriquez, MD, a Marco Manfrini, BSC ,d Gianluca Campo, MD
doi : 10.1016/j.jcin.2022.10.054
Volume 16, Issue 7, 10 April 2023, Pages 783-794
Post–percutaneous coronary intervention (PCI) quantitative flow ratio (QFR) values ≥0.90 are associated with a low incidence of adverse events.
Virtual PCI Powered by Augmented Reality: Pave the Way to Optimal Revascularization∗
Bo Xu, MBBS, a,b,y Rui Zhang, MD
doi : 10.1016/j.jcin.2022.11.012
Volume 16, Issue 7, 10 April 2023, Pages 795-797
Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT Trial
Antonio Landi, MD, a Dik Heg, PHD, b Enrico Frigoli, MD,a,b Pascal Vranckx, MD, PHD, c Stephan Windecker, MD, d Patrick Siegrist, MD,e Guillaume Cayla, MD, PHD, f Adrian Włodarczak, MD,g Stephane Cook, MD, h Iván Gómez-Blázquez, MD, i Yair Feld, MD, PH D, j Park Seung-Jung, MD, k Martin Mates, MD, l Chaim Lotan, MD, m Sengottuvelu Gunasekaran, MD, n Mamoru Nanasato, MD, o Rajiv Das, MD,p Henning Kelbæk, MD, q Emmanuel Teiger, MD, PH D, r Javier Escaned, MD,s Yuki Ishibashi, MD, P HD, t Gilles Montalescot, MD, u Hitoshi Matsuo, MD, PHD, v Dragan Debeljacki, MD, w Pieter C. Smits, MD, P HD, x Marco Valgimigli, MD, PHD, a,y on behalf of the MASTER DAPT Investigators
doi : 10.1016/j.jcin.2023.01.366
Volume 16, Issue 7, 10 April 2023, Pages 798-812
MASTER-DAPT: A Further Step Toward Long-Term P2Y12 Blocker Monotherapy After PCI∗
Freek W.A. Verheugt, MDVolume 16, Issue 7, 10 April 2023, Pages 813-815
Genetic-Guided Oral P2Y12 Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention
Brenden S. Ingraham, MD, a Michael E. Farkouh, MD, b Ryan J. Lennon, MS,c Derek So, MD,d Shaun G. Goodman, MD,e,f Nancy Geller, PHD, g Jang-Ho Bae, MD, h Myung Ho Jeong, MD,i Linnea M. Baudhuin, PHD, j Verghese Mathew, MD, k Malcolm R. Bell, MD,a Amir Lerman, MD, a Yi-Ping Fu, PHD, g Ahmed Hasan, MD, P HD, g Erin Iturriaga, DNP, g Jean-Francois Tanguay, MD,l Robert C. Welsh, MD,m Yves Rosenberg, MD, MPH, g Kent Bailey, PH D, c Charanjit Rihal, MD, a Naveen L. Pereira, MDa
doi : 10.1016/j.jcin.2023.01.356
Volume 16, Issue 7, 10 April 2023, Pages 816-825
Genetic-guided P2Y12 inhibitor selection has been proposed to reduce ischemic events by identifying CYP2C19 loss-of-function (LOF) carriers at increased risk with clopidogrel treatment after percutaneous coronary intervention (PCI).
Another Step Toward CYP2C19 Genotype-Guided Therapy in Treatment With Dual Antiplatelet Therapy∗
Jurriën M. ten Berg, MD, PH D, a,b Wout W.A. van den Broek, MD
doi : 10.1016/j.jcin.2023.02.008
Volume 16, Issue 7, 10 April 2023, Pages 826-828
Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention
Seung Hun Lee, MD, PH D, a,b, * Young-Hoon Jeong, MD, P HD, c, * David Hong, MD, b Ki Hong Choi, MD, PHD, b Joo Myung Lee, MD, MPH, P HD, b Taek Kyu Park, MD, PHD, b Jeong Hoon Yang, MD, P HD, b Joo-Yong Hahn, MD, P HD, b Seung-Hyuck Choi, MD, PHD, b Hyeon-Cheol Gwon, MD, PHD, b Myung Ho Jeong, MD, P HD, a Byeong-Keuk Kim, MD, P HD, d Hyung Joon Joo, MD, PHD, e Kiyuk Chang, MD, P HD, f Yongwhi Park, MD, PHD, g,h Sung Gyun Ahn, MD, P HD, i Jung-Won Suh, MD, P HD, j,k Sang Yeub Lee, MD, PH D, c Jung Rae Cho, MD, PHD, l Ae-Young Her, MD, PHD, m Hyo-Soo Kim, MD, PH D, n Moo Hyun Kim, MD, PHD, o Do-Sun Lim, MD, P HD, e Eun-Seok Shin, MD, PHD, p Young Bin Song, MD, PHD, b on behalf of the PTRG-DES Registry Investigators
doi : 10.1016/j.jcin.2023.01.363
Volume 16, Issue 7, 10 April 2023, Pages 829-843
Although there is a growing body of evidence that CYP2C19 genotyping can be beneficial when considering treatment with clopidogrel after percutaneous coronary intervention (PCI), whether a genotype-guided strategy can be generally adopted in routine practice remains unclear among East Asians.
Genotype-Guided Selection of Antiplatelet Therapy: The Evidence Moves East∗
Larisa H. Cavallari, PHARMD, a Francesco Franchi, MD
doi : 10.1016/j.jcin.2023.02.021
Volume 16, Issue 7, 10 April 2023, Pages 844-846
SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backup
Cindy L. Grines, MD, Chaira Lyndon C. Box, MD b Mamas A. Mamas, MD c J. Dawn Abbott, MD d James C. Blankenship, MDe Jeffrey G. Carr, MD f, * Nick Curzen, P HD g,y William D.T. Kent, MD, MSC h Yazan Khatib, MD i Alexis Matteau, MD j,z Jennifer A. Rymer, MD, MBA, MHS k,x Theodore L. Schreiber, MD l Poonam Velagapudi, MD, MS m,jj Mladen I. Vidovich, MDn Stephen W. Waldo, MDo Arnold H. Seto, MD, MPA, Vice-Chair
doi : 10.1016/j.jcin.2022.12.016
Volume 16, Issue 7, 10 April 2023, Pages 847-860
Unusual Intracoronary Structure Mimicking Stent Deformation: Observation by Multimodality Imaging
Yusuke Osanai, MD,* Osamu Kurihara, MD, PH D,* Nobuaki Kobayashi, MD, PHD, Masamichi Takano, MD, PHD, Yasushi Miyauchi, MD, P HD
doi : 10.1016/j.jcin.2022.10.059
Volume 16, Issue 7, 10 April 2023, Pages 861-862
Virtual 2-Stent Bifurcation Percutaneous Coronary Intervention Using the Fractional Flow Reserve Computed Tomography Planner
Hirofumi Ohashi, MD, P HD, a,b Carlo Zivelonghi, MD, PHD, c Ruiko Seki, MD,a Koshiro Sakai, MD, P HD, a,d Carlos Collet, MD, PH D, a Benjamin Scott, MD, c Paul Vermeersch, MD, PH D, c Pierfrancesco Agostoni, MD, PH D
doi : 10.1016/j.jcin.2022.11.027
Volume 16, Issue 7, 10 April 2023, Pages 863-864
Impact of Severe Serial Coronary Stenoses on iFR Pullback Assessment
Roberto Scarsini, MD, PHD, Andrea Bottardi, MD, Flavio Ribichini, MD, Gabriele Pesarini, MD, P HD
doi : 10.1016/j.jcin.2023.01.005
Volume 16, Issue 7, 10 April 2023, Pages 865-867
Double Inversion Technique for Multivessel Primary PCI in Dextrocardia
Domenico Angellotti, MD, Giovanni Esposito, MD, PH D, Raffaele Piccolo, MD, PH D
doi : 10.1016/j.jcin.2023.01.019
Volume 16, Issue 7, 10 April 2023, Pages 868-869
Superficial Radial Artery: Atypical Alternative to Radial Access
Jacek Klaudel, MD, P HD, Wojciech Trenkner, MD, Piotr Radowski, MD, Bartłomiej Ziniewicz, MD, Dariusz Surman, MD, Urszula Kossakowska, MD, Michał Smolarczyk, MD
doi : 10.1016/j.jcin.2023.01.365
Volume 16, Issue 7, 10 April 2023, Pages 870-871
Absolute Flow and Resistance Have Superior Repeatability as Compared to CFRÂ and IMR: EDIT-CMD Substudy
Tijn P.J. Jansen, MD Annemiek de Vos, MD Valeria Paradies, MD Peter Damman, MD, PhD Steven Teerenstra, PhD Regina E. Konst, MD Aukelien Dimitriu-Leen, MD, PhD Angela H.E.M. Maas, MD, PhD Pieter C. Smits, MD, PhD Suzette E. Elias-Smale, MD, PhD *Niels van Royen, MD, PhD
doi : 10.1016/j.jcin.2022.11.019
Volume 16, Issue 7, 10 April 2023, Pages 872-874
Immediate vs Delayed Coronary Angiography for Out-of-Hospital Cardiac Arrest: A Meta-Analysis of Randomized Controlled Trials
Amartya Kundu, MD Nakeya Dewaswala, MD Huzefa Bhopalwala, MD David J. Moliterno, MD
doi : 10.1016/j.jcin.2022.11.031
Volume 16, Issue 7, 10 April 2023, Pages 875-877
Randomized Controlled Trial of Conventional Versus MicroNet-Covered Stent in Carotid Artery Revascularization: 12-Month Outcomes
Andrey Karpenko, MD, PhD Savr Bugurov, MD Pavel Ignatenko, MD, PhD Vladimir Starodubtsev, MD, PhD Irina Popova, MD, PhD Krzysztof Malinowski, MSc yPiotr Musialek, MD, Dphil
doi : 10.1016/j.jcin.2023.01.369
Volume 16, Issue 7, 10 April 2023, Pages 878-880
JACC Journals’ Pathway Forward With AI Tools: The Future Is Now
Valentin Fuster, MD, PH D, Editor-in-Chief, Journal of the American College of Cardiology Biykem Bozkurt, MD, P HD, Editor-in-Chief, JACC: Heart Failure Y. Chandrashekhar, MD, DM, Editor-in-Chief, JACC: Cardiovascular Imaging Julia Grapsa, MD, PHD, Editor-in-Chief, JACC: Case Reports Bonnie Ky, MD, Editor-in-Chief, JACC: CardioOncology Douglas L. Mann, MD, Editor-in-Chief, JACC: Basic to Translational Science David J. Moliterno, MD, Editor-in-Chief, JACC: Cardiovascular Interventions Kalyanam Shivkumar, MD, PH D, Editor-in-Chief, JACC: Clinical Electrophysiology Candice K. Silversides, MD, Editor-in-Chief, JACC: Advances Justine Varieur Turco, MA, Divisional Vice President, American College of Cardiology Jian’an Wang, MD, PHD, Editor-in-Chief, JACC: Asia
doi : 10.1016/j.jcin.2023.03.001
Volume 16, Issue 7, 10 April 2023, Pages 881-883
